Quantcast
Home > Quotes > BMRN
BMRN

BioMarin Pharmaceutical Inc. Common Stock (BMRN) Quote & Summary Data

$93.71
*  
1.99
2.08%
Get BMRN Alerts
*Delayed - data as of Nov. 19, 2018  -  Find a broker to begin trading BMRN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    BMRN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
123
Today's High / Low
$ 96.07 / $ 92.37
Share Volume
847,792
50 Day Avg. Daily Volume
1,243,675
Previous Close
$ 95.70
52 Week High / Low
$ 106.74 / $ 75.81
Market Cap
16,686,199,953
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.72
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.6

Intraday Chart

Shares Traded

Share Volume:
847,792
50 Day Avg. Daily Volume:
1,243,675

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.72

Trading Range

The current last sale of $93.71 is 23.61% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 96.07 $ 106.74
 Low: $ 92.37 $ 75.81

ETFs with BMRN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.78% VanEck Vectors Biotech ETF (BBH) -0.56 (-0.48%)
3.54% Principal Healthcare Innovators Index ETF (BTEC) -5.93 (-16.47%)
2.38% iShares Nasdaq Biotechnology Index Fund (IBB) -5.15 (-4.77%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

BioMarin Pharmaceutical Inc. (BioMarin, we, us or our) is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. We select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a significant benefit over existing products. Our therapy portfolio consists of six commercial products and multiple clinical and pre-clinical product candidates.  ... More ...  


Risk Grade

Where does BMRN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 95.59
Open Date:
Nov. 19, 2018
Close Price:
$ 93.71
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x